Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
MousePheno	abnormal pharyngeal arch morphology	SETD2 VCAN FRS2 AKAP13 PTCH1 ECE1	9.68e-06	171	41	6	MP:0002884
MousePheno	decreased atrioventricular cushion size	VCAN SNAI2 ECE1	1.85e-05	18	41	3	MP:0000301
MousePheno	abnormal craniofacial development	SETD2 ZFHX4 VCAN SNAI2 FRS2 AKAP13 PTCH1 ECE1	2.70e-05	425	41	8	MP:0003935
MousePheno	abnormal mandibular ramus morphology	CACNA1S ZFHX4 PTCH1	3.98e-05	23	41	3	MP:0010150
MousePheno	alisphenoid bone hypoplasia	PTCH1 ECE1	5.02e-05	4	41	2	MP:0004460
MousePheno	absent subplate	MAP1B TMEM94	5.02e-05	4	41	2	MP:0008443
MousePheno	abnormal fetal size	CACNA1S TMEM94 VCAN FRS2 PTCH1 MEIS2	6.10e-05	237	41	6	MP:0004198
MousePheno	abnormal secondary palate morphology	CACNA1S ZFHX4 SNAI2 PTCH1 ECE1	9.62e-05	159	41	5	MP:0013550
MousePheno	small male preputial gland	NHLH2 PTCH1	1.75e-04	7	41	2	MP:0002716
MousePheno	dilated sarcoplasmic reticulum	CACNA1S DMD	2.32e-04	8	41	2	MP:0004089
MousePheno	abnormal fetal growth/weight/body size	CACNA1S TMEM94 VCAN FRS2 PTCH1 MEIS2	2.74e-04	312	41	6	MP:0004197
MousePheno	small pharyngeal arch	SETD2 AKAP13 PTCH1	2.85e-04	44	41	3	MP:0006346
MousePheno	small alisphenoid bone	PTCH1 ECE1	2.98e-04	9	41	2	MP:0004459
MousePheno	abnormal subplate morphology	MAP1B TMEM94	2.98e-04	9	41	2	MP:0008440
MousePheno	small mandibular coronoid process	CACNA1S PTCH1	2.98e-04	9	41	2	MP:0030283
MousePheno	cleft secondary palate	CACNA1S ZFHX4 SNAI2 PTCH1	5.07e-04	127	41	4	MP:0009890
Domain	CH	EHBP1 NAV3 DMD	7.87e-04	65	52	3	SM00033
Domain	CH	EHBP1 NAV3 DMD	9.77e-04	70	52	3	PF00307
Domain	-	EHBP1 NAV3 DMD	1.02e-03	71	52	3	1.10.418.10
Domain	CH	EHBP1 NAV3 DMD	1.10e-03	73	52	3	PS50021
Domain	CH-domain	EHBP1 NAV3 DMD	1.19e-03	75	52	3	IPR001715
Domain	SEA	MUC16 MUC12	1.69e-03	22	52	2	PF01390
Domain	SEA	MUC16 MUC12	1.85e-03	23	52	2	PS50024
Domain	SEA_dom	MUC16 MUC12	1.85e-03	23	52	2	IPR000082
Pubmed	Genetic reduction of the extracellular matrix protein versican attenuates inflammatory cell infiltration and improves contractile function in dystrophic mdx diaphragm muscles.	VCAN DMD	2.19e-06	2	52	2	32632164
Pubmed	Dihydropyridine receptor gene expression in skeletal muscle from mdx and control mice.	CACNA1S DMD	2.19e-06	2	52	2	9540851
Pubmed	BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain.	PRUNE2 AKAP13	6.57e-06	3	52	2	18445682
Pubmed	Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.	MUC16 MUC12	6.57e-06	3	52	2	26770020
Pubmed	Assignment of the centromere protein H (Cenph) gene to mouse chromosome band 13D1 by in situ hybridization and interspecific backcross analyses.	MAP1B VCAN	6.57e-06	3	52	2	11060445
Pubmed	Stromal-epithelial crosstalk regulates kidney progenitor cell differentiation.	FAT4 SNAI2 MEIS2	8.00e-06	26	52	3	23974041
Pubmed	Zeb1 controls neuron differentiation and germinal zone exit by a mesenchymal-epithelial-like transition.	SNAI2 PTCH1 MEIS2	8.99e-06	27	52	3	27178982
Pubmed	Ciliary Hedgehog Signaling Restricts Injury-Induced Adipogenesis.	DMD PTCH1	1.31e-05	4	52	2	28709001
Pubmed	The transcription factor Slug represses p16Ink4a and regulates murine muscle stem cell aging.	SNAI2 DMD	1.31e-05	4	52	2	31189923
Pubmed	Laminin-511 is an epithelial message promoting dermal papilla development and function during early hair morphogenesis.	VCAN SNAI2 PTCH1	1.99e-05	35	52	3	18676816
Pubmed	Developmental hourglass and heterochronic shifts in fin and limb development.	VCAN PTCH1	2.19e-05	5	52	2	33560225
Pubmed	An ankyrin-based mechanism for functional organization of dystrophin and dystroglycan.	ANK3 DMD	2.19e-05	5	52	2	19109891
Pubmed	Axon initial segment-associated microglia.	ANK3 VCAN	2.19e-05	5	52	2	25653382
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	SETD2 LIMA1 MAP1B SEC16A NCAPH MEIS2	2.86e-05	399	52	6	35987950
Pubmed	A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2-Bispecific Antibody for Combination Cancer Therapy.	EHBP1 ANK3 TMEM94 SEC16A FRS2 DMD	3.86e-05	421	52	6	36976175
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	EHBP1 LIMA1 ARHGEF28 MAP1B SEC16A AKAP13 USP54 DOP1B	3.92e-05	861	52	8	36931259
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	EHBP1 ANK3 SEC16A FRS2 USP54	4.63e-05	263	52	5	34702444
Pubmed	Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway.	ANK3 DMD	6.10e-05	8	52	2	28826662
Pubmed	A human MAP kinase interactome.	EHBP1 ANK3 NAV3 AKAP13 MUC12 DMD	8.53e-05	486	52	6	20936779
Pubmed	AAV-mediated intramuscular delivery of myotubularin corrects the myotubular myopathy phenotype in targeted murine muscle and suggests a function in plasma membrane homeostasis.	CACNA1S DMD	9.79e-05	10	52	2	18434328
Pubmed	Amotl1 mediates sequestration of the Hippo effector Yap1 downstream of Fat4 to restrict heart growth.	FAT4 SNAI2	1.20e-04	11	52	2	28239148
Pubmed	Absence of alpha-syntrophin leads to structurally aberrant neuromuscular synapses deficient in utrophin.	ANK3 DMD	1.20e-04	11	52	2	10995443
Pubmed	Meta-analysis of genome-wide association data of bipolar disorder and major depressive disorder.	FAT4 ANK3	1.20e-04	11	52	2	20351715
Pubmed	Combined genetic-pharmacologic inactivation of tightly linked ADAMTS proteases in temporally specific windows uncovers distinct roles for versican proteolysis and glypican-6 in cardiac development.	VCAN PTCH1	1.20e-04	11	52	2	38750698
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	SETD2 FAT4 SEC16A RIPOR1 DMD ECE1 NCAPH	1.25e-04	754	52	7	35906200
Pubmed	BMP2 expression in the endocardial lineage is required for AV endocardial cushion maturation and remodeling.	VCAN SNAI2	1.43e-04	12	52	2	28790014
Pubmed	miR-30 family microRNAs regulate myogenic differentiation and provide negative feedback on the microRNA pathway.	SNAI2 DMD	1.43e-04	12	52	2	25689854
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	FAT4 ANK3 SEC16A FRS2 MUC16 SMCR8 NCAPH	1.51e-04	777	52	7	35844135
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	SETD2 LIMA1 ANK3 MAP1B SEC16A NCAPH	1.66e-04	549	52	6	38280479
Pubmed	Gli2 influences proliferation in the developing lung through regulation of cyclin expression.	VCAN PTCH1	1.69e-04	13	52	2	19574535
Pubmed	Molecular determinants of epithelial mesenchymal transition in mouse placenta and trophoblast stem cell.	VCAN SNAI2	1.97e-04	14	52	2	37414855
Pubmed	The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer.	ZFHX4 NHLH2 MEIS2	1.97e-04	75	52	3	37298722
Pubmed	SR protein kinases promote splicing of nonconsensus introns.	RLF ANK3 ZFHX4 AKAP13 ECE1	2.04e-04	361	52	5	26167880
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	RGMA TMEM94 SEC16A RIPOR1 AKAP13 PTCH1 ECE1 TEP1	2.20e-04	1105	52	8	35748872
Pubmed	Molecular heterogeneity of developing retinal ganglion and amacrine cells revealed through single cell gene expression profiling.	NHLH2 MEIS2	2.60e-04	16	52	2	17444492
Pubmed	Hedgehog-Activated Fat4 and PCP Pathways Mediate Mesenchymal Cell Clustering and Villus Formation in Gut Development.	FAT4 PTCH1	2.94e-04	17	52	2	32155439
Pubmed	Structural basis and sequence rules for substrate recognition by Tankyrase explain the basis for cherubism disease.	CACNA1S FAT4	2.94e-04	17	52	2	22153077
Pubmed	Cytoplasmic Metadherin (MTDH) provides survival advantage under conditions of stress by acting as RNA-binding protein.	JADE3 ECE1 TEP1 DOP1B	2.99e-04	214	52	4	22199357
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	RLF EHBP1 PRUNE2 ANK3 MAP1B PLPP1 RIPOR1 AKAP13 TEP1	3.29e-04	1489	52	9	28611215
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC16 MUC12	3.30e-04	18	52	2	18834073
Pubmed	Effect of expression alteration in flanking genes on phenotypes of St8sia2-deficient mice.	RGMA AKAP13	3.30e-04	18	52	2	31541165
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TMEM94 SEC16A NAV3 RIPOR1 DOP1B	3.54e-04	407	52	5	12693553
Pubmed	Systematic identification of cancer cell vulnerabilities to natural killer cell-mediated immune surveillance.	EHBP1 MAP1B USP54 DCAF4	3.68e-04	226	52	4	31452512
Pubmed	An integrated genetic map of the pearl locus of mouse chromosome 13.	MAP1B VCAN	3.69e-04	19	52	2	8828042
Pubmed	Cancer Stem Cells Regulate Cancer-Associated Fibroblasts via Activation of Hedgehog Signaling in Mammary Gland Tumors.	VCAN PTCH1	3.69e-04	19	52	2	28202523
Pubmed	A census of human transcription factors: function, expression and evolution.	ZFHX4 ESRRB SNAI2 NHLH2 MLLT3 MEIS2 ZNF551	3.89e-04	908	52	7	19274049
Pubmed	Sequential roles of Hedgehog and Wnt signaling in osteoblast development.	FRS2 PTCH1	4.09e-04	20	52	2	15576404
Pubmed	Gene expression profiling of the developing mouse kidney and embryo.	VCAN SNAI2	4.09e-04	20	52	2	19998061
Pubmed	Kif7 is required for the patterning and differentiation of the diaphragm in a model of syndromic congenital diaphragmatic hernia.	PTCH1 MEIS2	4.52e-04	21	52	2	23650387
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	PRUNE2 CACNA1S ANK3 AKAP13 PTCH1	4.55e-04	430	52	5	35044719
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	EHBP1 SETD2 LIMA1 MAP1B SEC16A SMCR8 NCAPH	4.60e-04	934	52	7	33916271
Pubmed	Regulation of retinoic acid distribution is required for proximodistal patterning and outgrowth of the developing mouse limb.	PTCH1 MEIS2	4.97e-04	22	52	2	15030763
Pubmed	Neural crest cells require Meis2 for patterning the mandibular arch via the Sonic hedgehog pathway.	PTCH1 MEIS2	5.44e-04	23	52	2	32616504
Pubmed	Secreted metalloproteases ADAMTS9 and ADAMTS20 have a non-canonical role in ciliary vesicle growth during ciliogenesis.	VCAN PTCH1	5.44e-04	23	52	2	30814516
Pubmed	Pbx1/Pbx2 requirement for distal limb patterning is mediated by the hierarchical control of Hox gene spatial distribution and Shh expression.	PTCH1 MEIS2	5.44e-04	23	52	2	16672333
Pubmed	Sequence comparison of human and mouse genes reveals a homologous block structure in the promoter regions.	EHBP1 LIMA1 ANK3 VCAN FRS2 ECE1 SMCR8 DOP1B	6.27e-04	1293	52	8	15342556
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	EHBP1 ANK3 MAP1B SEC16A FRS2 SMCR8	6.40e-04	708	52	6	39231216
Pubmed	Identification and characterization of cellular heterogeneity within the developing renal interstitium.	SNAI2 MEIS2	6.43e-04	25	52	2	32586976
Pubmed	Endocardial Brg1 disruption illustrates the developmental origins of semilunar valve disease.	VCAN FRS2	6.43e-04	25	52	2	26100917
Pubmed	Delineating the early transcriptional specification of the mammalian trachea and esophagus.	PTCH1 MEIS2	6.43e-04	25	52	2	32515350
Pubmed	A cluster of three long-range enhancers directs regional Shh expression in the epithelial linings.	PTCH1 MEIS2	6.43e-04	25	52	2	19369396
Pubmed	Genomic analysis of mouse retinal development.	ZFHX4 TMEM94 ESRRB NAV3 NHLH2 ECE1 NCAPH	7.14e-04	1006	52	7	15226823
Pubmed	Expressed sequence tag analysis of human RPE/choroid for the NEIBank Project: over 6000 non-redundant transcripts, novel genes and splice variants.	EHBP1 TAF1C PARM1	7.27e-04	117	52	3	12107410
Pubmed	A novel source of arterial valve cells linked to bicuspid aortic valve without raphe in mice.	VCAN SNAI2	7.51e-04	27	52	2	29956664
Pubmed	Hydroureternephrosis due to loss of Sox9-regulated smooth muscle cell differentiation of the ureteric mesenchyme.	VCAN PTCH1	8.08e-04	28	52	2	20881014
Pubmed	The cellular and molecular landscape of hypothalamic patterning and differentiation from embryonic to late postnatal development.	NHLH2 MEIS2	8.08e-04	28	52	2	32868762
Pubmed	The SOX2-interactome in brain cancer cells identifies the requirement of MSI2 and USP9X for the growth of brain tumor cells.	SETD2 ZFHX4 SEC16A MEIS2	8.44e-04	282	52	4	23667531
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	EHBP1 SETD2 JADE3 SEC16A MLLT3 RIPOR1 DMD	8.57e-04	1038	52	7	26673895
Pubmed	Temporospatial regulation of intraflagellar transport is required for the endochondral ossification in mice.	SNAI2 PTCH1	8.67e-04	29	52	2	34929174
Pubmed	ADAMTS18 Deficiency Leads to Pulmonary Hypoplasia and Bronchial Microfibril Accumulation.	SNAI2 PTCH1	9.29e-04	30	52	2	32882513
Pubmed	Multiple roles of mesenchymal beta-catenin during murine limb patterning.	PTCH1 MEIS2	9.29e-04	30	52	2	16495310
Pubmed	Molecular profiling of the vestibular lamina highlights a key role for Hedgehog signalling.	PTCH1 MEIS2	9.92e-04	31	52	2	36971701
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SETD2 LIMA1 JADE3 SEC16A RIPOR1 ZNF551	1.02e-03	774	52	6	15302935
Pubmed	Mef2d is essential for the maturation and integrity of retinal photoreceptor and bipolar cells.	CACNA1S ESRRB	1.06e-03	32	52	2	25757744
Pubmed	Sema6D acts downstream of bone morphogenetic protein signalling to promote atrioventricular cushion development in mice.	VCAN SNAI2	1.26e-03	35	52	2	28172500
Pubmed	β-Catenin regulates endocardial cushion growth by suppressing p21.	VCAN SNAI2	1.26e-03	35	52	2	37385754
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	SETD2 ZFHX4 TAF1C SEC16A USP54 TEP1 ZNF574	1.30e-03	1116	52	7	31753913
Pubmed	Proximity labeling reveals dynamic changes in the SQSTM1 protein network.	MAP1B JADE3 SEC16A USP54	1.38e-03	322	52	4	39098523
Pubmed	Myocardial β-Catenin-BMP2 signaling promotes mesenchymal cell proliferation during endocardial cushion formation.	VCAN SNAI2	1.49e-03	38	52	2	30201295
Pubmed	Control of cardiac jelly dynamics by NOTCH1 and NRG1 defines the building plan for trabeculation.	RLF VCAN	1.49e-03	38	52	2	29743679
Pubmed	Expansion of the renal capsular stroma, ureteric bud branching defects and cryptorchidism in mice with Wilms tumor 1 gene deletion in the stromal compartment of the developing kidney.	FAT4 PTCH1	1.49e-03	38	52	2	32715478
Cytoband	20q13.32	PPP4R1L ZNF831	2.36e-04	20	52	2	20q13.32
Cytoband	1p36.12	CELA3A VWA5B1	9.08e-04	39	52	2	1p36.12
GeneFamily	CD molecules\|Mucins	MUC16 MUC12	6.64e-04	21	33	2	648
Coexpression	HAY_BONE_MARROW_STROMAL	FNDC1 LIMA1 ARHGEF28 ZFHX4 PLPP1 LRFN5 SNAI2 NAV3 DMD MEIS2	2.26e-06	767	52	10	M39209
Coexpression	FAN_EMBRYONIC_CTX_EX_2_EXCITATORY_NEURON	ZFHX4 MLLT3 MEIS2	4.05e-06	16	52	3	M39025
Coexpression	ONDER_CDH1_TARGETS_2_UP	PRUNE2 FAT4 ZFHX4 MAP1B VCAN MLLT3	1.17e-05	257	52	6	M13867
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	RLF EHBP1 SETD2 MAP1B NAV3 AKAP13 DMD MEIS2 DOP1B	4.23e-05	856	52	9	M4500
Coexpression	GSE41867_NAIVE_VS_DAY15_LCMV_ARMSTRONG_EFFECTOR_CD8_TCELL_DN	SETD2 TAF1C FRS2 DMD SMCR8	4.67e-05	199	52	5	M9501
Coexpression	GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS	MAP1B VCAN SNAI2 RIPOR1 DMD PTCH1 MEIS2	5.98e-05	505	52	7	M39167
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	EHBP1 PRUNE2 ARHGEF28 ANK3 AKAP13	7.67e-05	221	52	5	M39222
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder mesenchyme_emap-3087_top-relative-expression-ranked_1000	FNDC1 LIMA1 ZFHX4 MAP1B PLPP1 JADE3 LRFN5 VCAN MEIS2 PARM1	3.02e-05	837	52	10	gudmap_developingLowerUrinaryTract_e13.5_bladder mesenchyme_1000
CoexpressionAtlas	DevelopingKidney_e14.5 whole kidney - Wnt4 KO_emap-6674_top-relative-expression-ranked_500	RGMA EHBP1 FAT4 ZFHX4 PTCH1 MEIS2 PARM1	4.25e-05	388	52	7	gudmap_developingKidney_e14.5 whole kidney - Wnt4 KO_500
CoexpressionAtlas	FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#4	FAT4 ZFHX4 LRFN5 SNAI2 NAV3 PPP4R1L MLLT3 AKAP13	8.78e-05	591	52	8	Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_2500_K4
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_1000	FAT4 LIMA1 ZFHX4 MAP1B VCAN NAV3 MLLT3 AKAP13 MEIS2	9.30e-05	769	52	9	gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000
CoexpressionAtlas	DevelopingKidney_e15.5_Ureteral Smooth Musc_emap-28812_top-relative-expression-ranked_1000	EHBP1 PRUNE2 FAT4 ZFHX4 MAP1B LRFN5 VCAN MEIS2 ZNF551	9.58e-05	772	52	9	gudmap_developingKidney_e15.5_Ureteral Smooth Musc_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000	FAT4 ANK3 ZFHX4 MAP1B VCAN MLLT3 AKAP13 PTCH1 PARM1	1.33e-04	806	52	9	gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000
CoexpressionAtlas	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2	RGMA EHBP1 FAT4 VCAN SNAI2 SEC16A NAV3 MLLT3 RIPOR1 DMD MEIS2	1.35e-04	1208	52	11	facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RGMA ZFHX4 MAP1B LRFN5 DMD MEIS2 PARM1	1.55e-09	178	52	7	d4ecb84e9b1f4ec49c519321156aa10f9bd34cce
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RGMA ZFHX4 MAP1B PLPP1 LRFN5 NAV3 MEIS2	2.53e-09	191	52	7	2c51850f5c559d665b8a27a12b75af9ed58dffe1
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 MAP1B LRFN5 VCAN NAV3 DMD MEIS2	2.53e-09	191	52	7	107113b930d9ad171f1b2aa20df4567c94fae7d8
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 MAP1B LRFN5 VCAN NAV3 DMD MEIS2	2.53e-09	191	52	7	bc353a79a1d11ca52bba5e3874a80d432e1a7715
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 MAP1B LRFN5 VCAN NAV3 DMD MEIS2	2.63e-09	192	52	7	d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	RGMA ZFHX4 MAP1B LRFN5 NAV3 DMD MEIS2	2.72e-09	193	52	7	09a9ab029f01234459a88e3e994fe90ef4cbb8c6
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	RGMA ZFHX4 MAP1B LRFN5 NAV3 DMD MEIS2	2.82e-09	194	52	7	c49f72441b3557e2c3a9c4239e68c0cf0652814b
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RLF PRUNE2 FNDC1 ZFHX4 TEP1 NCAPH	4.22e-08	167	52	6	f5bffa77061baec0ba87bd688a047595f32534db
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 MAP1B VCAN SNAI2 DMD PTCH1	7.27e-08	183	52	6	af8d86f15a549064530d94bd47081daf59d58ecd
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 FNDC1 ANK3 MAP1B DMD PTCH1	8.00e-08	186	52	6	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RGMA ZFHX4 LRFN5 NAV3 DMD MEIS2	8.53e-08	188	52	6	ce85a56ac27a6432421dde93a1bafa8b943244b9
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 FNDC1 VCAN SNAI2 PTCH1 PARM1	9.08e-08	190	52	6	c01a8bfb9fbc0e6f37d7e9be25512eda63acabbc
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	RGMA ZFHX4 LRFN5 NAV3 DMD MEIS2	9.08e-08	190	52	6	efb757f11c2809e66ddb48a5c84f5433f111cb7c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 MAP1B LRFN5 VCAN DMD MEIS2	9.08e-08	190	52	6	70c86dd454afb21d4a85db56c5f369d4b342bc97
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 LRFN5 VCAN NAV3 DMD MEIS2	9.66e-08	192	52	6	5105e4b577408b4e1a62d0a44c23c2b830ccad88
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGMA PRUNE2 MAP1B DMD MEIS2 PARM1	9.66e-08	192	52	6	d0fb6885f023d55a2b7984c99db9c6463258f788
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 ZFHX4 MAP1B VCAN DMD MEIS2	1.06e-07	195	52	6	49c99553629cdd83ee56a2e508d5bc8d34b8507b
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 ZFHX4 MAP1B VCAN DMD MEIS2	1.06e-07	195	52	6	dd281a249854800f737dc22e0f375f66dfb5cf5f
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 PLPP1 VCAN SNAI2 BEND4 MEIS2	1.16e-07	198	52	6	bba40ece261741fa8c0e28de768af001d28f04f8
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 PLPP1 VCAN SNAI2 BEND4 MEIS2	1.19e-07	199	52	6	01ab0363558f215f9979e20fd5170d8fee149cea
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGMA FNDC1 VCAN SNAI2 PTCH1 MEIS2	1.19e-07	199	52	6	36c1deac7ef0f9ebde6b2f7a63f7daa03d8c139a
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 PLPP1 VCAN SNAI2 BEND4 MEIS2	1.19e-07	199	52	6	8d71e1fc92ee24deedf23fbb1a85a7fba0d8d436
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 PLPP1 VCAN SNAI2 BEND4 MEIS2	1.19e-07	199	52	6	1f5ad0f1971156b28a8d46a380bda906b5fdbedc
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 PLPP1 VCAN SNAI2 BEND4 MEIS2	1.19e-07	199	52	6	08bdcabc3fce787578a8eb66fc8412b0974fa6cc
ToppCell	Fibroblasts-CD34+_Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	FNDC1 LIMA1 ZFHX4 PLPP1 VCAN SNAI2	1.19e-07	199	52	6	13ff7409e200a0b46cdb7924d15ef33639693622
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FAT4 FNDC1 PLPP1 VCAN SNAI2 PTCH1	1.19e-07	199	52	6	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	FNDC1 ANK3 ZFHX4 MLLT3 DMD PTCH1	1.19e-07	199	52	6	6b3a0e5d52a30d0eed30e6a670f5b53bc233f70c
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 PLPP1 VCAN SNAI2 BEND4 MEIS2	1.19e-07	199	52	6	49690494270981eec5b5261c59e0545dff90cc21
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	FAT4 FNDC1 ZFHX4 VCAN DMD PTCH1	1.23e-07	200	52	6	a799fc7bb83ad0524362cb5010df949741fb7bf3
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	FNDC1 ANK3 ZFHX4 MLLT3 DMD PTCH1	1.23e-07	200	52	6	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 FNDC1 ANK3 MAP1B DMD PTCH1	1.23e-07	200	52	6	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	PRUNE2 FNDC1 ANK3 MAP1B DMD PTCH1	1.23e-07	200	52	6	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	3'-GW_trimst-1-SmallIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 PLPP1 VCAN SNAI2 PTCH1 MEIS2	1.23e-07	200	52	6	3dacd0afe69bc16bb33336ea9ea99a9cd47731d9
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	PRUNE2 FNDC1 ZFHX4 MAP1B DMD PTCH1	1.23e-07	200	52	6	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	Adult-Mesenchymal-chondrocyte-D175\|Adult / Lineage, Cell type, age group and donor	ZFHX4 MAP1B LRFN5 NAV3 ECE1	1.54e-06	168	52	5	14071b961c9bdb54a8259b12a88237b802cbde36
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 MAP1B LRFN5 DMD MEIS2	1.68e-06	171	52	5	972fab891135bd755d5526cbc5a963200067b0a6
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 MAP1B LRFN5 DMD MEIS2	1.68e-06	171	52	5	2a77ed79c6f2e700e789c80451a70ecb31639719
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 SNAI2 DMD PTCH1 MEIS2	2.05e-06	178	52	5	78a0c6340001a77f5b2d890b6263f574af2e72da
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PLPP1 FRS2 MUC12 ZNF831 NCAPH	2.05e-06	178	52	5	8151e5d73407fd9cba382b69a2bc707c81790c7f
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT4 LIMA1 MAP1B ECE1 MEIS2	2.22e-06	181	52	5	4d7793026373cbcf04b15c77f95f1025d07d4c00
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 MAP1B VCAN SNAI2 NAV3	2.22e-06	181	52	5	c6d2a13df3b74fade3b0c71e285b4c14c8e52413
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGMA PRUNE2 MAP1B DMD MEIS2	2.22e-06	181	52	5	ab0f300d14b62cef57f1b0bdae143b8dfe8e6975
ToppCell	kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 MAP1B VCAN SNAI2 NAV3	2.22e-06	181	52	5	c62b0a2422377ffadaab63edd538e87a06fa5017
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 ZFHX4 VCAN NAV3 MEIS2	2.28e-06	182	52	5	3dfa9187e9d2bab1d199079d29209c4648220ada
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	PRUNE2 FNDC1 USH1G DMD PARM1	2.35e-06	183	52	5	a1d4f25e13f5b9e92a9ca0a804a7bed5df8fb2fe
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FAT4 LIMA1 MAP1B ECE1 MEIS2	2.35e-06	183	52	5	3427f3cbe6ea81709750e7dd3ff378f03ae65eab
ToppCell	343B-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2\|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells)	PLPP1 FRS2 MUC12 ZNF831 NCAPH	2.41e-06	184	52	5	2c2125b8030af83f7a6d59a7102d4de8e0ac1988
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B NAV3 DMD MEIS2 PARM1	2.41e-06	184	52	5	e061e85c4bb19f49f6451ddd7a9077d7378ee365
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FNDC1 ANK3 ZFHX4 DMD PTCH1	2.47e-06	185	52	5	6712512100ccef456d2e2bd201d0987986c92ac9
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FNDC1 ANK3 ZFHX4 DMD PTCH1	2.47e-06	185	52	5	3b2dfc8f4c87be516265dbecfc251276034d0efd
ToppCell	COVID-19-kidney-Fibroblast-1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	ZFHX4 MAP1B LRFN5 DMD MEIS2	2.61e-06	187	52	5	76bfe8c42430a230a8bdf299575c444fb7780f24
ToppCell	3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 VCAN SNAI2 PTCH1 PARM1	2.61e-06	187	52	5	173f029dcf32af008f517912f6d110a33a9e98cf
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 FNDC1 ANK3 DMD PTCH1	2.68e-06	188	52	5	3177b2c1723268d330d3e9f24f9e24492ace6286
ToppCell	LA-13._Vascular_Smooth_Muscle\|LA / Chamber and Cluster_Paper	PRUNE2 ARHGEF28 PLPP1 DMD PARM1	2.68e-06	188	52	5	34e1b074a3995aa46ab194eb45115d76d1a5514d
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 FNDC1 ANK3 DMD PTCH1	2.68e-06	188	52	5	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 USH1G NAV3 RIPOR1 ECE1	2.68e-06	188	52	5	a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c
ToppCell	droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ARHGEF28 USH1G NAV3 RIPOR1 ECE1	2.68e-06	188	52	5	54550313db78b3b5b572fa1e67092c8f6f33aab5
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 MAP1B SEC16A AKAP13 ECE1	2.68e-06	188	52	5	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRFN5 VCAN DMD PTCH1 MEIS2	2.75e-06	189	52	5	71397e993a77d70b2eeede240bdfc7660b558987
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRFN5 VCAN DMD PTCH1 MEIS2	2.75e-06	189	52	5	4eea4759520c312bd17a681034d8074e47093d2b
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 FNDC1 MAP1B DMD PTCH1	2.75e-06	189	52	5	45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 MAP1B LRFN5 DMD MEIS2	2.82e-06	190	52	5	1121eb607a984c59fbffe7220837fc178745aa55
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 MAP1B LRFN5 DMD MEIS2	2.82e-06	190	52	5	048b581e3f7ea9fc2f87c0532974bba85c7292c2
ToppCell	COVID-19-lung-Artery_EC\|COVID-19 / Disease (COVID-19 only), tissue and cell type	FAT4 LIMA1 PLPP1 ECE1 MEIS2	2.82e-06	190	52	5	07b675befcd1d0a9c90cb17b5d22323468325d51
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 VCAN SNAI2 PTCH1 PARM1	2.89e-06	191	52	5	89d03c4133dda852a3713c0902a7d67941cf5b21
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 LRFN5 VCAN DMD MEIS2	2.89e-06	191	52	5	39092a0aff8097617820c59f5fea9ee2bb4f63a2
ToppCell	Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PRUNE2 FNDC1 ANK3 DMD PTCH1	2.89e-06	191	52	5	b133ee1c0e58d00ddd2e4e05b01fd04947524c18
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 LRFN5 VCAN DMD MEIS2	2.89e-06	191	52	5	ee5f1b1c59029c46cbb1a00935c03b9317bb9da9
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B LRFN5 DMD PTCH1 MEIS2	2.97e-06	192	52	5	bc84b9ce01b4d826a682842ab8a395dac9b91183
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell-Mesoderm_2_(ZEB2+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 FNDC1 VCAN SNAI2 MEIS2	2.97e-06	192	52	5	f053b89bfd6048c227667ff01c38df7c51d8a496
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1B LRFN5 DMD PTCH1 MEIS2	2.97e-06	192	52	5	0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-myocytic\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 MAP1B SNAI2 DMD PTCH1	3.04e-06	193	52	5	146e8c148478ab61b1c1dbaf1ee98a8cd4a0ff8a
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGMA PRUNE2 FNDC1 DMD MEIS2	3.04e-06	193	52	5	a402e736440684ebe123673b6b0c6fcd8fa057b2
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 MAP1B DMD MEIS2 PARM1	3.04e-06	193	52	5	c8c21eee8c6c086dc2faf416669cd4a002870fbe
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 MAP1B DMD MEIS2 PARM1	3.04e-06	193	52	5	5b602b1702283184bd3943c2a6f2290b7c37e407
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRFN5 VCAN DMD PTCH1 MEIS2	3.12e-06	194	52	5	cf0244a29934e515446ac917d3c30672b460fb04
ToppCell	(7)_MNP-(7)_DC_1\|(7)_MNP / Spleen cell shreds - cell class (v1) and cell subclass (v1)	LIMA1 PLPP1 DMD NCAPH PARM1	3.12e-06	194	52	5	8dbe0188e2af6f14b3b44e5213fbdd581128082f
ToppCell	Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-E\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ANK3 MAP1B NHLH2 MLLT3 MEIS2	3.12e-06	194	52	5	b111d10c99d7ff7eb261cd7786cd9d9a549049b1
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 LRFN5 DMD PTCH1 MEIS2	3.12e-06	194	52	5	e03ba6caed59fa64d4d9b042593469d4a6a3dc10
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	LRFN5 VCAN DMD PTCH1 MEIS2	3.12e-06	194	52	5	ba7f971fb9a19423602da60770f23d9fead4a451
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 MAP1B VCAN DMD MEIS2	3.12e-06	194	52	5	ebb038f94f49f5c655578d1b018676e10c6b7e3c
ToppCell	facs-Thymus-Thymus_Epithelium\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 PLPP1 SNAI2 NAV3 DMD	3.28e-06	196	52	5	6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363
ToppCell	facs-Thymus-Thymus_Epithelium-18m\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZFHX4 PLPP1 SNAI2 NAV3 DMD	3.28e-06	196	52	5	c8c89e469402e11aa2a9561e859b6fd1fb66c39b
ToppCell	IPF-Stromal-Myofibroblast\|World / Disease state, Lineage and Cell class	FAT4 MAP1B LRFN5 SNAI2 NAV3	3.28e-06	196	52	5	7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-immature_mesenchymal_cell\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 FNDC1 VCAN SNAI2 MEIS2	3.28e-06	196	52	5	cbfe01ba8071864e19b37028236ae35789f630fe
ToppCell	10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast_precursor\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	RGMA FNDC1 ZFHX4 MAP1B SNAI2	3.28e-06	196	52	5	57df2a57b35be9851ac0b1e5731baa53052511f0
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 MAP1B VCAN DMD MEIS2	3.28e-06	196	52	5	fa445f4240c521cf04eb2e2f79a5c55fda31209a
ToppCell	renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	FNDC1 MAP1B VCAN DMD MEIS2	3.28e-06	196	52	5	802f61e78a9a1030a86c4a980c398a73cd4d1574
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Newborn\|World / Primary Cells by Cluster	MAP1B VCAN MLLT3 MEIS2 DOP1B	3.28e-06	196	52	5	9401bd84798f0ea3e986e94135a9e1dc5643330f
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 MAP1B VCAN DMD MEIS2	3.28e-06	196	52	5	3a6c942e2907aa07b5e12dbf9019d18f7bfca507
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 MAP1B VCAN DMD MEIS2	3.28e-06	196	52	5	bba88e91cd3e3a6f5a9b443e3a4da33c5b455e70
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ZFHX4 MAP1B VCAN NAV3 PARM1	3.36e-06	197	52	5	2744cc94883c5d0424677cf5093bbab622933e9b
ToppCell	5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 VCAN SNAI2 PTCH1 PARM1	3.36e-06	197	52	5	236a40eb6c08e1d179cf0fb5450b032975c5f6b6
ToppCell	5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RGMA PRUNE2 FNDC1 MAP1B MEIS2	3.36e-06	197	52	5	94a7270ea6d4b586f58875c9e4071ce0f683ef7e
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT4 MAP1B VCAN NAV3 PTCH1	3.36e-06	197	52	5	44673c38384453207871d3fd8e8ba9093cc06bc5
ToppCell	3'-Pediatric_IBD-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 PLPP1 VCAN SNAI2 PTCH1	3.45e-06	198	52	5	0f4052a59c6bd89dab637d6ef1214460d6cbcf55
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ZFHX4 MAP1B DMD MEIS2 PARM1	3.45e-06	198	52	5	79576525a10ed3e3a9d1608077cd16ecda23376f
ToppCell	COVID-19-kidney-Fibroblast-2\|kidney / Disease (COVID-19 only), tissue and cell type	MAP1B LRFN5 VCAN NAV3 MEIS2	3.45e-06	198	52	5	ca26ca460856b1faaa3e83766da6abdf63af2b51
ToppCell	3'-GW_trimst-2-SmallIntestine-Mesenchymal\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FNDC1 PLPP1 VCAN SNAI2 MEIS2	3.45e-06	198	52	5	ebceb11f50b8a6ebb7629fdbd3d31fb131ace6fd
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 FNDC1 VCAN SNAI2 PTCH1	3.45e-06	198	52	5	7582ee9ec8a87ecb094201f1f9191b412f9d2875
Drug	Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A	ARHGEF28 ZFHX4 MAP1B VCAN NAV3 RIPOR1 ECE1	3.03e-07	196	52	7	5827_DN
Drug	LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A	ARHGEF28 ZFHX4 AP5Z1 AKAP13 ECE1 ZNF551	5.52e-06	196	52	6	5236_UP
Drug	Pentolinium bitartrate [52-62-0]; Down 200; 7.4uM; MCF7; HT_HG-U133A	EHBP1 SETD2 AP5Z1 TAF1C AKAP13 ECE1	5.68e-06	197	52	6	4699_DN
Drug	Praziquantel [55268-74-1]; Down 200; 12.8uM; PC3; HT_HG-U133A	SETD2 ARHGEF28 VCAN RIPOR1 PTCH1 DOP1B	5.68e-06	197	52	6	5874_DN
Drug	Zardaverine [101975-10-4]; Down 200; 15uM; PC3; HT_HG-U133A	ANK3 VCAN NAV3 ECE1 TEP1 DCAF4	6.02e-06	199	52	6	4209_DN
Drug	17-AAG; Down 200; 1uM; PC3; HT_HG-U133A	ARHGEF28 AP5Z1 NAV3 AKAP13 ZNF574	6.91e-05	188	52	5	1218_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A	EHBP1 SETD2 MAP1B ECE1 TEP1	7.44e-05	191	52	5	4303_DN
Drug	Homochlorcyclizine dihydrochloride [1982-36-1]; Up 200; 10.4uM; MCF7; HT_HG-U133A	ARHGEF28 SNAI2 MLLT3 RIPOR1 AKAP13	7.44e-05	191	52	5	7417_UP
Drug	pioglitazone HCl; Down 200; 10uM; PC3; HT_HG-U133A	ANK3 VCAN NAV3 MLLT3 PARM1	7.63e-05	192	52	5	5930_DN
Drug	geldanamycin; Down 200; 1uM; PC3; HT_HG-U133A	ARHGEF28 TAF1C RIPOR1 ECE1 DCAF4	7.82e-05	193	52	5	1228_DN
Drug	5213008; Up 200; 18uM; MCF7; HT_HG-U133A_EA	ANK3 SNAI2 FRS2 AKAP13 PTCH1	8.01e-05	194	52	5	898_UP
Drug	LY 294002; Down 200; 10uM; PC3; HT_HG-U133A	EHBP1 RIPOR1 AKAP13 ECE1 DCAF4	8.21e-05	195	52	5	1239_DN
Drug	Cimetidine [51481-61-9]; Down 200; 15.8uM; PC3; HT_HG-U133A	EHBP1 SETD2 ANK3 MAP1B ECE1	8.41e-05	196	52	5	4063_DN
Drug	Repaglinide [135062-02-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A	ARHGEF28 TAF1C VCAN ECE1 TEP1	8.41e-05	196	52	5	3558_UP
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; PC3; HT_HG-U133A	SETD2 MAP1B AP5Z1 AKAP13 ZNF551	8.41e-05	196	52	5	7276_UP
Drug	Minaprine dihydrochloride [25953-17-7]; Up 200; 10.8uM; HL60; HG-U133A	EHBP1 SETD2 AP5Z1 AKAP13 ZNF574	8.41e-05	196	52	5	1968_UP
Drug	Torsemide [56211-40-6]; Up 200; 11.4uM; MCF7; HT_HG-U133A	FAT4 ZFHX4 AP5Z1 TEP1 ZNF551	8.41e-05	196	52	5	3517_UP
Drug	Allantoin [97-59-6]; Up 200; 25.2uM; MCF7; HT_HG-U133A	SETD2 TAF1C SNAI2 AKAP13 DCAF4	8.61e-05	197	52	5	1678_UP
Drug	Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	EHBP1 SETD2 SNAI2 MLLT3 AKAP13	8.61e-05	197	52	5	1691_UP
Drug	Rapamycin; Up 200; 0.1uM; MCF7; HT_HG-U133A	ANK3 TAF1C SNAI2 ECE1 TEP1	8.61e-05	197	52	5	6940_UP
Drug	Bumetanide [28395-03-1]; Down 200; 11uM; MCF7; HT_HG-U133A	MAP1B TMEM94 AP5Z1 SNAI2 AKAP13	8.61e-05	197	52	5	7440_DN
Drug	SC 19220; Down 200; 10uM; MCF7; HT_HG-U133A	SETD2 FRS2 TEP1 DCAF4 ZNF551	8.61e-05	197	52	5	7060_DN
Drug	Homatropine hydrobromide (R,S) [51-56-9]; Up 200; 11.2uM; HL60; HT_HG-U133A	EHBP1 VCAN MLLT3 PTCH1 ZNF551	8.61e-05	197	52	5	1848_UP
Drug	Nifurtimox [23256-30-6]; Up 200; 14uM; HL60; HT_HG-U133A	ANK3 TAF1C FRS2 DMD ZNF574	8.61e-05	197	52	5	2908_UP
Drug	Alverine citrate salt [5560-59-8]; Up 200; 8.4uM; PC3; HT_HG-U133A	SETD2 ARHGEF28 MAP1B FRS2 DCAF4	8.61e-05	197	52	5	2110_UP
Drug	Amitryptiline hydrochloride [549-18-8]; Up 200; 12.8uM; MCF7; HT_HG-U133A	PRUNE2 ARHGEF28 AP5Z1 GPR52 PTCH1	8.82e-05	198	52	5	5453_UP
Drug	Norethynodrel [68-23-5]; Down 200; 13.4uM; PC3; HT_HG-U133A	EHBP1 ANK3 JADE3 NAV3 AKAP13	8.82e-05	198	52	5	1818_DN
Drug	Heptaminol hydrochloride [543-15-7]; Down 200; 22uM; PC3; HT_HG-U133A	MAP1B AP5Z1 RIPOR1 ECE1 ZNF574	8.82e-05	198	52	5	1825_DN
Drug	2-Chloropyrazine [14508-49-7]; Up 200; 35uM; MCF7; HT_HG-U133A	ARHGEF28 TAF1C AKAP13 TEP1 DCAF4	9.03e-05	199	52	5	3570_UP
Drug	Lidoflazine [3416-26-0]; Down 200; 8.2uM; PC3; HT_HG-U133A	FAT4 ANK3 TAF1C NAV3 ECE1	9.03e-05	199	52	5	5804_DN
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	ARHGEF28 AP5Z1 AKAP13 ECE1 PARM1	9.03e-05	199	52	5	7539_UP
Drug	FIGLU	MAP1B VCAN FRS2	9.69e-05	39	52	3	CID000000909
Disease	Congenital Heart Defects	TMEM94 ECE1 MEIS2	6.13e-05	44	51	3	C0018798
Disease	Embryonal Rhabdomyosarcoma	SETD2 DMD	8.15e-05	8	51	2	C0206656
Disease	cardiotoxicity, response to anthracycline-based chemotherapy	PRUNE2 BEND4	2.63e-04	14	51	2	EFO_0005257, EFO_1001482
Disease	hepcidin:transferrin saturation ratio	MUC16 ZNF551	3.03e-04	15	51	2	EFO_0007902
Disease	opioid dependence	RGMA FAT4 MAP1B RIPOR1	7.54e-04	237	51	4	EFO_0005611
Disease	depressive symptom measurement	EHBP1 LRFN5 BEND4 PTCH1 ECE1	8.34e-04	426	51	5	EFO_0007006
Disease	Abnormality of refraction	RGMA ANK3 LRFN5 MLLT3 AKAP13 BEND4	1.04e-03	673	51	6	HP_0000539
Disease	colorectal cancer, overall survival	LRFN5 BEND4	1.15e-03	29	51	2	EFO_0000638, MONDO_0005575
Disease	spine bone mineral density	ANK3 PTCH1 ZNF551	1.16e-03	119	51	3	EFO_0007701
Disease	Papillary Renal Cell Carcinoma	SETD2 NAV3 AKAP13	1.43e-03	128	51	3	C1306837
Disease	Renal Cell Carcinoma	SETD2 NAV3 AKAP13	1.43e-03	128	51	3	C0007134
Disease	Sarcomatoid Renal Cell Carcinoma	SETD2 NAV3 AKAP13	1.43e-03	128	51	3	C1266043
Disease	Chromophobe Renal Cell Carcinoma	SETD2 NAV3 AKAP13	1.43e-03	128	51	3	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	SETD2 NAV3 AKAP13	1.43e-03	128	51	3	C1266044
Disease	joint hypermobility measurement	FNDC1 VCAN	1.49e-03	33	51	2	EFO_0007905
Disease	systolic blood pressure, body mass index	CACNA1S CELA3A	1.59e-03	34	51	2	EFO_0004340, EFO_0006335

Protein segments in the cluster

Peptide	Gene	Start	Entry
EPAHSEVSTDSGHDS	USH1G	291	Q495M9
HDSGHGDDESPSTSS	DCAF4	41	Q8WV16
TSVHISHISDSEGPS	VCAN	1976	P13611
SDSESSSASSPLHHE	MLLT3	451	P42568
DGIPAPESSSDSDSH	FAT4	4831	Q6V0I7
SHGHPSSSTLPEEEE	BEND4	301	Q6ZU67
TSESDSHHEHPFPGD	AKAP13	256	Q12802
HSPATSSTHSEEGAE	AP5Z1	731	O43299
APASSPQLSHDDTHS	DMD	3421	P11532
HIHEPDPGSSDISTS	LRFN5	386	Q96NI6
LDTSHTESPTPHDSN	ARHGEF28	1651	Q8N1W1
SSGHESPSSVLPDSE	MUC16	7486	Q8WXI7
SPSLHAEVGSPHSTE	MAP1B	1571	P46821
ADHPPAEVTSHAASG	LIMA1	101	Q9UHB6
HDDATSTHSAGTPGP	MEIS2	221	O14770
PDRTAHGAPDSSEHT	DOP1B	1096	Q9Y3R5
HGAPDSSEHTESADT	DOP1B	1101	Q9Y3R5
TSSESIDLPLSHHGS	NAV3	1371	Q8IVL0
PTEESSSDHTPTSHA	PARM1	196	Q6UWI2
SSDHTPTSHATAEPV	PARM1	201	Q6UWI2
SHEVDSSRETGHSPD	GPR52	246	Q9Y2T5
SSTPGSLHEETPHSR	CACNA1S	1756	Q13698
PSSHSSSRVVHGEDA	CELA3A	21	P09093
FGDASSHPSSRHPSV	FRS2	156	Q8WU20
PHSGAAEEDSSASAP	FNDC1	701	Q4ZHG4
SHSDTEESVTDHAGP	ANK3	2476	Q12955
SEHQTPDDHLSPSTA	EHBP1	626	Q8NDI1
ESSHEGLITDPHSPS	ECE1	721	P42892
SSPSSGIDALSHHSP	ESRRB	21	O95718
HSSSSSDGPAESPVE	PPP4R1L	346	Q9P1A2
DQQPHSPDSSSSVHS	JADE3	561	Q92613
SDPLPATSSHSGDSA	nan	831	A6NNC1
SGAHSSSQDPPADHI	FER1L6	1121	Q2WGJ9
DTHSPDAPAASGTSE	PRUNE2	1261	Q8WUY3
SLSGHVDPSEDTSSP	TAF1C	761	Q15572
SDHPSSAHSDPESLG	NHLH2	11	Q02577
EEDSHTTLHETPTTG	PLPP1	261	O14494
PSDTSSKDHSGSESP	SNAI2	91	O43623
PGHTHSGSDSSDSEY	PTCH1	1211	Q13635
TSGSHAPASDDTPEF	RGMA	61	Q96B86
VLPSTPAHTHSDEDG	SMCR8	596	Q8TEV9
PAHTHSDEDGVVSSP	SMCR8	601	Q8TEV9
SSETRGHPHSASSPS	NCAPH	16	Q15003
DEDSSATPHQHGFTP	ZFHX4	581	Q86UP3
TSGDSESHPEPTDHV	TEP1	226	Q99973
ERTEHSHSPGDSSAP	RLF	1621	Q13129
TGAPDATLHTVHPDS	SEC16A	506	O15027
PPHSSHEDLTDGLST	TMEM94	441	Q12767
PSPSSLDQHLGDHSS	ZNF574	346	Q6ZN55
HEATPSGEEPHSSSS	ZNF551	196	Q7Z340
SHPQSDGVDSTSHTD	SETD2	1161	Q9BYW2
SPLHSLSEHSAESEG	ZNF831	361	Q5JPB2
TSTDPAPSAHLDSVH	RIPOR1	521	Q6ZS17
TSDSRSPGDLEPSHH	VWA5B1	761	Q5TIE3
EPSHHPSAFETETSS	VWA5B1	771	Q5TIE3
PASCHESHSSLSPES	USP54	926	Q70EL1
ESHSSLSPESSAPQH	USP54	931	Q70EL1
TLGHSEESTPVHSSP	MUC12	466	Q9UKN1
HSSPGSTATTHFPDS	MUC12	886	Q9UKN1
FPHSTTTSVHGEEPT	MUC12	1316	Q9UKN1
GEEPTTFHSRPASTH	MUC12	1326	Q9UKN1
SHSQPGSTHTTAFPD	MUC12	1471	Q9UKN1
HSRPGSTHTTAFPDS	MUC12	2081	Q9UKN1
HSSPDASGTTPSSAH	MUC12	2276	Q9UKN1
HSSPGSTATTHFPDS	MUC12	3526	Q9UKN1
SHSQPGSTHTTAFPD	MUC12	4111	Q9UKN1